Xolair
Search results
Scope
Date
~
-
Bio & PharmaCelltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Bio & PharmaCelltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
1
Latest News
- 1 Korea’s top cinema chains seek merger to counter box office slump
- 2 S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
- 3 CJ CheilJedang to open $72 mn dumpling plant in Japan
- 4 LG Electronics breaks ground on $600 million home appliance plant in India
- 5 KakaoBank posts record Q1 profit, eyes Thai expansion after Indonesia
